PICC Inserted by a Nurse-led Vascular Access Team in Poland

Launched by MEDICAL UNIVERSITY OF WARSAW · May 15, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring the effectiveness and safety of placing a type of intravenous line called a PICC (Peripherally Inserted Central Catheter) by a specially trained nursing team in Poland. PICCs are used for patients who need long-term access to their veins for treatments like chemotherapy or nutrition that may irritate the veins. The goal is to see if having nurses perform this procedure can provide patients with better care and easier access to their treatments.

To participate in this trial, you need to be over 18 years old and require intravenous therapy that needs a central vein, especially if your veins are hard to access. You must also be able to give consent to join the study. However, if you already have a central line in place, have certain skin issues, or are pregnant, you may not be eligible. Participants will receive the PICC line placement from the trained nursing team, and the trial aims to ensure that this method is both safe and effective for patients needing long-term intravenous therapy.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age \>18 years
• • Intravenous therapy with solutions requiring central vein cannulation (irritant drugs, extreme pH \<5 and \>9, osmolarity \> 600 mOsm/l), e.g., chemotherapy, parenteral nutrition with osmolarity \>900 mOsm/l
• • Difficult intravenous access with multiple blood collection
• • Ability to consent to participate in the study
• • Consent to participate in the study
• Exclusion Criteria:
• • Presence of central venous catheter, such as. centrally inserted central catheter or totally implanted vascular device
• • Indication of another type of vascular access device
• • Lack of veins suitable for cannulation of the arm
• • Infection, burns or other skin lesion on the upper extremities (involving the site of planned catheter insertion and attachment)
• • Pregnancy (confirmed by history and review of medical records or confirmed by positive human chorionic gonadotropin (hCG) determination in urine or plasma)
• • Lack of patient consent to participate in the study
• • Lack of capacity to consent to participate in the study
• • No physician present to supervise the procedure